The medical community is buzzing with anticipation surrounding retatrutide, a novel dual GIP and GLP-1 target that’s demonstrating significant efficacy in clinical trials for managing obesity. Unlike some current weight loss approaches, retatrutide appears to deliver a significant substantial loss in body size and improve metabolic markers, part… Read More